This company has been marked as potentially delisted and may not be actively trading. Orexigen Therapeutics (OREX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock OREX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Orexigen Therapeutics Stock Price HistoryJune 21, 2025 | investing.comAardvark Therapeutics, Inc. Announces Key Leadership Appointments to Enhance Scientific, Commercial, and Regulatory ExpertiseMay 21, 2025 | nasdaq.comAardvark Therapeutics Expands Management Team with Two Key HiresSeptember 11, 2024 | finance.yahoo.comTemporary Animal Adoption Center Opens In The Avenue At White MarshAugust 15, 2024 | msn.comXeno Biosciences Announces New CEO and FinancingApril 17, 2024 | businesswire.comOrexigen Tanks After-Hours on Obesity DataAugust 27, 2023 | thestreet.comRegulus Therapeutics Inc.: Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent UpdatesAugust 9, 2023 | finanznachrichten.deTriumvira Immunologics Strengthens its Leadership Team with Three Accomplished Life Sciences ExecutivesJuly 20, 2023 | finance.yahoo.comMAPLIGHT THERAPEUTICS APPOINTS KRIS HANSON AS GENERAL COUNSELJune 20, 2023 | markets.businessinsider.com2023 "Anti-obesity Drugs Market" Key Manufacturers and Regional Outlook 2031May 17, 2023 | marketwatch.comGlobal Anti-obesity Medicine Market Size 2023-2031 Market Dynamics by Absolute Reports | with [86 Pages]May 16, 2023 | marketwatch.comThe global Weight Loss Therapeutics market Size during the period of 2023 to 2030 is expected grow at CAGR of 11.3%May 5, 2023 | marketwatch.comZevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of DirectorsMarch 30, 2023 | finance.yahoo.comAnti-Obesity Drugs Market Factual Overview Research Report 2023-2030March 30, 2023 | marketwatch.comGlobal Anti-Obesity Drugs Market Size 2023 to 2026 Size and Share Survey ReportMarch 29, 2023 | marketwatch.comAnti Obesity Drugs Market Size and Forecast till 2028March 28, 2023 | marketwatch.comAnti-Obesity Drugs Market New Innovations and Future Expansion 2023-2031March 28, 2023 | marketwatch.comAnti-Obesity Drugs (Anti-obesity Medication) Market Share and Forecast till 2028March 21, 2023 | marketwatch.comAnti Obesity Drugs Market Continues Aggressive Growth till 2028March 13, 2023 | marketwatch.comThe Weight Loss Therapeutics Market 2023 is Expected to Udergo Significant Changes Due to New Technologies and Other Industry Related Factors 2030March 8, 2023 | marketwatch.com2023-2029 Anti-Obesity Prescription Drugs Market Size and Growth Analysis | Research Report by Absolute ReportsMarch 6, 2023 | marketwatch.comAnti-obesity Drugs Market International Business Analysis, Development Outlook and Regional Strategies 2028February 23, 2023 | marketwatch.comWeight Loss Therapeutics Market Shows Huge Demand by Shares, Size, Future Trends and Future Scope Including Top Players by 2023-2028December 8, 2022 | marketwatch.comAnti-obesity Medicine Market 2023 | Future Growth Segments, Latest Opportunities, Industry Revenue, Size, Share and Leading Players Forecast to 2028November 18, 2022 | marketwatch.comWeight Loss Therapeutics Market Size And Opportunities for New Players, Forecast from 2022 To 2028October 13, 2022 | marketwatch.comOrexigen to Post Obesity Data in Race With Vivus, ArenaSeptember 6, 2022 | thestreet.comObesity Management Market Size 2022 : Technological Advancements in Report & Recent Innovations, Value Chain Analysis Till 2028 | 87 Report PagesSeptember 6, 2022 | marketwatch.comOrexigen Weight-Loss Pill Shows Surprise Heart-Safety BenefitAugust 21, 2022 | thestreet.comAnti-obesity Drugs Market Size 2022 Share, Growth By Top Company, Business Opportunity, Region, Application, Driver, Trends and Forecasts By 2028August 17, 2022 | marketwatch.comAnti-obesity Medicine Market Size to rise at 16.2% CAGR through 2028July 23, 2022 | marketwatch.comLilly's experimental obesity drug may be a 'multibillion-dollar opportunity'May 2, 2022 | morningstar.comMLilly's experimental weight-loss drug may be a 'multibillion-dollar opportunity'April 30, 2022 | morningstar.comMBinge Eating Disorder Market Global Trends, Segmentation and Opportunities Forecast To 2027April 25, 2022 | marketwatch.comHow Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval?January 14, 2022 | thestreet.comMetropolitan West Total Return Bond Fund Plan Class (MWTSX)November 17, 2021 | finance.yahoo.comNavamedic ASA extends exclusive distribution rights for Mysimba in the NordicsOctober 12, 2021 | finance.yahoo.comFederal Courts Make 2 Basic Errors In Virus Coverage RulingsSeptember 30, 2021 | law360.comSesen Bio Strengthens Executive Leadership Team as the Company Approaches the Potential Approval and Commercial Launch of Vicineum™August 11, 2021 | in.finance.yahoo.com Get Orexigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OREX and its competitors with MarketBeat's FREE daily newsletter. Email Address OREX Media Mentions By Week OREX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OREX News Sentiment▼0.000.46▲Average Medical News Sentiment OREX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OREX Articles This Week▼00▲OREX Articles Average Week Get Orexigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OREX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News GILD News VRTX News REGN News ALNY News BIIB News UTHR News INCY News NBIX News EXEL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OREX) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orexigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orexigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
